U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C35H37N3O2
Molecular Weight 531.6872
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of IMPLITAPIDE

SMILES

CC1=NC2=C(C3=C(C=CC=C3)N2CC4=CC=CC(=C4)[C@H](C5CCCC5)C(=O)N[C@@H](CO)C6=CC=CC=C6)C(C)=C1

InChI

InChIKey=AMNXBQPRODZJQR-DITALETJSA-N
InChI=1S/C35H37N3O2/c1-23-19-24(2)36-34-32(23)29-17-8-9-18-31(29)38(34)21-25-11-10-16-28(20-25)33(27-14-6-7-15-27)35(40)37-30(22-39)26-12-4-3-5-13-26/h3-5,8-13,16-20,27,30,33,39H,6-7,14-15,21-22H2,1-2H3,(H,37,40)/t30-,33-/m0/s1

HIDE SMILES / InChI

Molecular Formula C35H37N3O2
Molecular Weight 531.6872
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Implitapide is a microsomal triglyceride transfer protein (MTP) inhibitor with antihyperlipidemic activity. Microsomal triglyceride transfer protein (MTP) is essential for the synthesis of both chylomicron in the intestine and very low-density lipoprotein in the liver. In an animal model, inhibition of MTP by implitapide reduced both total cholesterol and triglyceride levels and suppressed progression of atherosclerotic lesions in apolipoprotein E knockout mice fed a Western-type diet.

Approval Year

PubMed

PubMed

TitleDatePubMed
Implitapide, a microsomal triglyceride transfer protein inhibitor, reduces progression of atherosclerosis in apolipoprotein E knockout mice fed a Western-type diet: involvement of the inhibition of postprandial triglyceride elevation.
2005 Feb
Patents

Patents

Sample Use Guides

mice: 3.2 mg/kg/day
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Sat Dec 16 16:39:18 GMT 2023
Edited
by admin
on Sat Dec 16 16:39:18 GMT 2023
Record UNII
Q70OH404HR
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
IMPLITAPIDE
INN   WHO-DD  
INN  
Official Name English
implitapide [INN]
Common Name English
(.ALPHA.S)-.ALPHA.-(.ALPHA.-(2,4-DIMETHYL-9H-PYRIDO(2,3-B)INDOL-9-YL)-P-TOLYL)-N-((.ALPHA.R)-.ALPHA.-(HYDROXYMETHYL)BENZYL)CYCLOPENTANEACETAMIDE
Common Name English
Implitapide [WHO-DD]
Common Name English
BAY-13-9952
Code English
Classification Tree Code System Code
FDA ORPHAN DRUG 188904
Created by admin on Sat Dec 16 16:39:19 GMT 2023 , Edited by admin on Sat Dec 16 16:39:19 GMT 2023
FDA ORPHAN DRUG 188704
Created by admin on Sat Dec 16 16:39:19 GMT 2023 , Edited by admin on Sat Dec 16 16:39:19 GMT 2023
NCI_THESAURUS C29703
Created by admin on Sat Dec 16 16:39:19 GMT 2023 , Edited by admin on Sat Dec 16 16:39:19 GMT 2023
Code System Code Type Description
CAS
177469-96-4
Created by admin on Sat Dec 16 16:39:18 GMT 2023 , Edited by admin on Sat Dec 16 16:39:18 GMT 2023
PRIMARY
PUBCHEM
5745206
Created by admin on Sat Dec 16 16:39:19 GMT 2023 , Edited by admin on Sat Dec 16 16:39:19 GMT 2023
PRIMARY
ChEMBL
CHEMBL2105804
Created by admin on Sat Dec 16 16:39:19 GMT 2023 , Edited by admin on Sat Dec 16 16:39:19 GMT 2023
PRIMARY
INN
7919
Created by admin on Sat Dec 16 16:39:19 GMT 2023 , Edited by admin on Sat Dec 16 16:39:19 GMT 2023
PRIMARY
FDA UNII
Q70OH404HR
Created by admin on Sat Dec 16 16:39:19 GMT 2023 , Edited by admin on Sat Dec 16 16:39:19 GMT 2023
PRIMARY
MESH
C443181
Created by admin on Sat Dec 16 16:39:19 GMT 2023 , Edited by admin on Sat Dec 16 16:39:19 GMT 2023
PRIMARY
NCI_THESAURUS
C65901
Created by admin on Sat Dec 16 16:39:19 GMT 2023 , Edited by admin on Sat Dec 16 16:39:19 GMT 2023
PRIMARY
DRUG BANK
DB04852
Created by admin on Sat Dec 16 16:39:19 GMT 2023 , Edited by admin on Sat Dec 16 16:39:19 GMT 2023
PRIMARY
EPA CompTox
DTXSID70870136
Created by admin on Sat Dec 16 16:39:19 GMT 2023 , Edited by admin on Sat Dec 16 16:39:19 GMT 2023
PRIMARY
SMS_ID
300000019131
Created by admin on Sat Dec 16 16:39:19 GMT 2023 , Edited by admin on Sat Dec 16 16:39:19 GMT 2023
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY